Table of Contents

company-logo

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and the People's Republic of China. The company offers medical related consulting services, including research studies, executive education, daily online executive briefings, tailored expert advisory services, and consulting and management services in the areas of immunotherapy and second opinion/referral services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells. It is also developing RNA-based FASH-CARTM cell therapy platform. In addition, the company develops avalon clinical-grade tissue-specific exosome (ACTEX); offers therapeutic and diagnostic targets utilizing QTY-code protein design technology with Massachusetts Institute of Technology (MIT), including using the QTY code protein design technology for development of a hemofiltration device to treat Cytokine Storm; and provides co-development of next generation, transposon-based, multi-target CAR-T, CAR-NK, and other immune effector cell therapeutic modalities with Arbele Limited. Further, it has strategic partnership with the University of Natural Resources and Life Sciences in Vienna and Austria to develop an S-layer vaccine that could be administered by an intranasal or oral route against SARS-CoV-2 and coronavirus that causes COVID-19 disease; and develops Avalon Cell and Avalon Rehab, as well as promotes standardization related to exosome industry. The company is headquartered in Freehold, New Jersey.

Avalon GloboCare Dividend Announcement

• Avalon GloboCare does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Avalon GloboCare dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Avalon GloboCare Dividend History

Avalon GloboCare Dividend Yield

Avalon GloboCare current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Avalon GloboCare stock? Use our calculator to estimate your expected dividend yield:

Avalon GloboCare Financial Ratios

P/E ratio-0.25
PEG ratio0.02
P/B ratio0.69
ROE-253.58%
Payout ratio0.00%
Current ratio0.11
Quick ratio0.11
Cash Ratio0.08

Avalon GloboCare Dividend FAQ

Does Avalon GloboCare stock pay dividends?
Avalon GloboCare does not currently pay dividends to its shareholders.
Has Avalon GloboCare ever paid a dividend?
No, Avalon GloboCare has no a history of paying dividends to its shareholders. Avalon GloboCare is not known for its dividend payments.
Why doesn't Avalon GloboCare pay dividends?
There are several potential reasons why Avalon GloboCare would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Avalon GloboCare ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Avalon GloboCare has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Avalon GloboCare a dividend aristocrat?
Avalon GloboCare is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Avalon GloboCare a dividend king?
Avalon GloboCare is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Avalon GloboCare a dividend stock?
No, Avalon GloboCare is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Avalon GloboCare stocks?
To buy Avalon GloboCare you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Avalon GloboCare stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.